Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Reinisch

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Alimentary Pharmacology & Therapeutics|September 8, 2017
Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapiesW Reinisch, S Lindgren
Alimentary Pharmacology & Therapeutics|September 6, 2016
Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors' replyN Narula, W Reinisch
Gut|August 15, 2006
Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancyS Angelberger, W Reinisch, C Dejaco
Alimentary Pharmacology & Therapeutics|January 4, 2013
Letter: Recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings--author's replyP Papay, S Winkler, W Reinisch
Alimentary Pharmacology & Therapeutics|May 5, 2011
Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapyS Danese, G Fiorino, W Reinisch
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 29, 2014
Common diagnostic flow charts for diagnosis and management of patients with an inflammatory bowel diseaseJ Martin-Comin, A Laghi, W Reinisch
Hematological Oncology|March 1, 1993
Evidence of colony suppressor activity and deficiency of hematopoietic growth factors in hairy cell leukemiaC Gasché, W Reinisch, J D Schwarzmeier
Gastroenterology|September 1, 1992
Interleukin-6 production in Crohn's diseaseC Gasché, W Reinisch, H Lochs, et al.
Alimentary Pharmacology & Therapeutics|January 19, 2012
C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT IW Reinisch, Y Wang, B J Oddens, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2013
Anaemia in inflammatory bowel disease: a population-based 10-year follow-upM L Høivik, W Reinisch, M Cvancarova, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Alimentary Pharmacology & Therapeutics|September 8, 2017
Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapiesW Reinisch, S Lindgren
Alimentary Pharmacology & Therapeutics|September 6, 2016
Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors' replyN Narula, W Reinisch
Gut|August 15, 2006
Prevention of abortion by ciclosporin treatment of fulminant ulcerative colitis during pregnancyS Angelberger, W Reinisch, C Dejaco
Alimentary Pharmacology & Therapeutics|January 4, 2013
Letter: Recommendations for the management of latent tuberculosis infection in IBD patients may not be applicable in all settings--author's replyP Papay, S Winkler, W Reinisch
Alimentary Pharmacology & Therapeutics|May 5, 2011
Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapyS Danese, G Fiorino, W Reinisch
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 29, 2014
Common diagnostic flow charts for diagnosis and management of patients with an inflammatory bowel diseaseJ Martin-Comin, A Laghi, W Reinisch
Hematological Oncology|March 1, 1993
Evidence of colony suppressor activity and deficiency of hematopoietic growth factors in hairy cell leukemiaC Gasché, W Reinisch, J D Schwarzmeier
Gastroenterology|September 1, 1992
Interleukin-6 production in Crohn's diseaseC Gasché, W Reinisch, H Lochs, et al.
Alimentary Pharmacology & Therapeutics|January 19, 2012
C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT IW Reinisch, Y Wang, B J Oddens, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2013
Anaemia in inflammatory bowel disease: a population-based 10-year follow-upM L Høivik, W Reinisch, M Cvancarova, et al.
Pageof 10